ArticleHaematologica2024

Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients.

Sridurga Mithraprabhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.